61 – 70 of 121
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer
(
- Contribution to journal › Article
-
Mark
Soluble HER3 predicts survival in bladder cancer patients
(
- Contribution to journal › Article
-
Mark
Molecular Characterization of Bladder Cancer Subtypes
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Recommendations for follow-up of muscle-invasive bladder cancer patients : A consensus by the international bladder cancer network
(
- Contribution to journal › Article
-
Mark
Molecular subtype profiling of urothelial carcinoma using a subtype-specific immunohistochemistry panel
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
(
- Contribution to journal › Article
-
Mark
Molecular classification of urothelial carcinoma : global mRNA classification versus tumour-cell phenotype classification
(
- Contribution to journal › Article
-
Mark
Second-look resection for primary stage T1 bladder cancer : a population-based study
(
- Contribution to journal › Article
-
Mark
Should we Refrain from Performing Oophorectomy in Conjunction with Radical Cystectomy for Bladder Cancer?
(
- Contribution to journal › Article
-
Mark
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer
(
- Contribution to journal › Article